No policy in case of life insurance shall be issued unless...
Category:
Non-Life
Latest
Six PSU general re/insurers promote 16 officials as GMs
The government is yet to decide about the dates for holding...
Wipro invests $66 million in US insurtech Aggne
EAST BRUNSWICK, N.J/TAMPA, Fla/ BENGALURU: “The Aggne team has a...
India’s COVID-19 caseload crosses 88-lakh mark
The number of active COVID-19 cases in the country stands at 4,79,216, which comprise 5.44 per cent of the total caseload, according to the data.
The total recoveries have surged to 82,05,728, pushing the national recovery rate to 93.09 per cent, while the fatality rate stands at 1.47 per cent.
Pfizer vaccine has ‘extraordinarily high degree of efficacy’: Fauci
“What I would hope is that even though there’s a degree of skepticism about vaccines in general, that when the general public sees how effective this vaccine is,” said Fauci, director of the National Institute of Allergy and Infectious Diseases, “we might see a turnaround of the attitude toward vaccination.”
China finds coronavirus on frozen beef, tripe from various countries
More than 7,500 people who may have had contact with the contaminated products and other related personnel have tested negative for the virus that causes COVID-19, it said.
Chinese authorities last week found the coronavirus on the packaging of Saudi shrimp in Lanzhou city, Brazilian beef in Wuhan city and Argentinian beef in Shandong and Jiangsu provinces.
Centre to provide 300 ICU beds to Delhi hospitals to tackle rising Covid-19 cases: Amit Shah
While India’s daily increase in cases has been under the 50,000 mark for eight straight days, around half its record peak, the city state of Delhi has recorded over 7,000 cases a day over the last five days – a record level.
“Delhi has witnessed a huge surge in daily active cases which is likely to worsen over next few weeks,” Harsh Vardhan said in a tweet on Sunday.
First batch of Sputnik V vaccine to reach Kanpur medical college for Phase 2, 3 trials
“As many as 180 volunteers have registered for the trials. Head of the research Saurabh Agarwal will determine the dosage of the vaccine to be administered. One dose will be administered and the condition of volunteers will be monitored to determine whether they need further doses or not,” R B Kamal,principal of Kanpur’s Ganesh Shankar Vidyarthi Medical College said
Bank of England warns insurers risk unexpected COVID losses
“Our work has highlighted that a number of firms have not been able to accurately identify and track COVID exposed policies, leading to unexpected COVID losses,” the BoE said in a letter to insurers.
“Firms should ensure that this uncertainty is reflected in the reserve estimates and that, where possible, appropriate procedures are put in place to identify and track exposed policies.”
Trust in vaccines vital to end pandemic, WHO says
But with the pandemic continuing to surge after already claiming some 1.3 million lives, she voiced deep concern at growing signs of vaccine hesitancy, with misinformation and mistrust coloring people’s acceptance of scientific advances.
More needed to be done to boost public “confidence in the fact that the vaccines that WHO is involved in evaluating, we will not be compromising on safety or efficacy,” she said.
PM inaugurates Ayurveda research & teaching instituteJamnagar,
“Institute of Teaching and Research in Ayurveda will be the first institution with institution of national importance status in the AYUSH sector, and this will enable the institution to be independent and innovative in the matter of deciding course content and pedagogy. The decision to set up the institute comes at a time when global interest in health solutions based on traditional wisdom is at an unprecedentedly high level and ITRA is poised to take Ayurveda education to new vistas,”
India to get 100 million AstraZeneca’s Covid vaccines next month: Serum Institute head
Drugmakers are just now getting data that will show how well their vaccine candidates work, but there are plenty of hurdles remaining as the global race to find an effective shot against the pathogen reaches its final stages. Astra and co-developer University of Oxford still need to see testing results. And even if their vaccine proves effective and gets a nod from regulators, there are questions over how easily and quickly the shot can be distributed
Japan’s Honda says will be first to mass-produce level 3 autonomous cars
“Honda is planning to launch sales of a Honda Legend (luxury sedan) equipped with the newly approved automated driving equipment before the end” of March 21, Honda said in a press release.